Home » Sign up for our e-Newsletter

Sign up for our e-Newsletter

November 2018 Question of the Month

Do you believe there are sufficient treatment options for HIV to warrant formulary exclusions?

Yes: 75%

No: 25%

Do you believe there are sufficient treatment options for Hemophilia to warrant formulary exclusions?

Yes: 71%

No: 29%

Do you believe there are sufficient treatment options for Hereditary Angioedema to warrant formulary exclusions?

Yes: 17%

No: 83%

How will state regulation and licensure of PBMs impact retail pharmacies? (select all that apply)

Improve pharmacy reimbursement rates: 5.88%

Add transparency to Rx reimbursement: 35.29%

Reduce PBM conflict of interests: 17.65%

Eliminate retrospective financial clawbacks: 17.65%

No impact: 11.76%

Reduce pharmacy reimbursement rates: 11.76%

How will the addition of step therapy on Medicare Part B drugs impact biosimilars?

Increase use of biosimilars: 54.55%

No Change: 36.36%

Decrease biosimilar use: 9.09%